Serum KL-6 levels reflect the severity of interstitial lung disease caused by immune checkpoint inhibitors

Serum KL-6 levels reflect the severity of interstitial lung disease caused by immune checkpoint inhibitors

Tumor immunotherapy, particularly immune checkpoint inhibitors (ICIs), has emerged as a powerful strategy in treating malignant tumors, exhibiting efficacy in both first-line and second-line treatments for advanced non-small cell lung cancer (NSCLC). Despite their success, ICIs can lead to adverse r...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoping Li, Dan Xue, Qiongying Wei, Xuexue Tan
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Immunobiology
Subjects:
KL-6
ICIs-ILD
Inflammatory factors
NSCLC
Online Access:http://www.sciencedirect.com/science/article/pii/S0171298524000846
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items